1-20 of 26
Authors: Gabriela Riemekasten
Journal Article
A comparative analysis of risk stratification tools in SSc-associated pulmonary arterial hypertension: a EUSTAR analysis
Rheumatology, keaf053, https://doi.org/10.1093/rheumatology/keaf053
Published: 29 January 2025
Journal Article
Preventive effects of early immunosuppressive treatment on the development of interstitial lung disease in systemic sclerosis
Rheumatology, keae375, https://doi.org/10.1093/rheumatology/keae375
Published: 22 July 2024
Journal Article
Anti-acid therapy in SSc-associated interstitial lung disease: long-term outcomes from the German Network for Systemic Sclerosis
Rheumatology, Volume 62, Issue 9, September 2023, Pages 3067–3074, https://doi.org/10.1093/rheumatology/kead023
Published: 27 January 2023
Journal Article
Autoimmune activation and hypersensitization of the AT1 and ETA receptors contributes to vascular injury in scleroderma renal crisis
Rheumatology, Volume 62, Issue 6, June 2023, Pages 2284–2293, https://doi.org/10.1093/rheumatology/keac594
Published: 13 October 2022
Journal Article
Systemic sclerosis-associated interstitial lung disease in the EUSTAR database: analysis by region
Rheumatology, Volume 62, Issue 6, June 2023, Pages 2178–2188, https://doi.org/10.1093/rheumatology/keac576
Published: 12 October 2022
Journal Article
Late skin fibrosis in systemic sclerosis: a study from the EUSTAR cohort
Rheumatology, Volume 62, Issue SI, February 2023, Pages SI54–SI63, https://doi.org/10.1093/rheumatology/keac363
Published: 22 June 2022
Journal Article
Immunological changes and prevention of disease progression through elotuzumab therapy in refractory IgG4-related sclerosing mesenteritis
Rheumatology, Volume 61, Issue 11, November 2022, Pages e334–e336, https://doi.org/10.1093/rheumatology/keac302
Published: 20 May 2022
Journal Article
Phenotype of limited cutaneous systemic sclerosis patients with positive anti-topoisomerase I antibodies: data from the EUSTAR cohort
Rheumatology, Volume 61, Issue 12, December 2022, Pages 4786–4796, https://doi.org/10.1093/rheumatology/keac188
Published: 28 March 2022
Journal Article
A patient with acute-onset hemorrhagic necroses and bullae of the legs
Rheumatology, Volume 60, Issue 11, November 2021, Pages 5476–5477, https://doi.org/10.1093/rheumatology/keab399
Published: 03 May 2021
Journal Article
Estimated glomerular filtration rate is a marker of mortality in the European Scleroderma Trials and Research Group (EUSTAR) database
Rheumatology, Volume 61, Issue 1, January 2022, Pages 213–222, https://doi.org/10.1093/rheumatology/keab302
Published: 26 March 2021
Journal Article
Immunoglobulin G of systemic sclerosis patients programs a pro-inflammatory and profibrotic phenotype in monocyte-like THP-1 cells
Rheumatology, Volume 60, Issue 6, June 2021, Pages 3012–3022, https://doi.org/10.1093/rheumatology/keaa747
Published: 23 November 2020
Journal Article
Older age onset of systemic sclerosis – accelerated disease progression in all disease subsets
Rheumatology, Volume 59, Issue 11, November 2020, Pages 3380–3389, https://doi.org/10.1093/rheumatology/keaa127
Published: 24 April 2020
Journal Article
197. INCREASED EXPRESSION OF THE COSTIMULATORY C-TYPE LECTIN (CD161) ON CIRCULATING PR3-SPECIFIC CD8+ and CD4+CD8+ T-CELLS IN GPA
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez061.012, https://doi.org/10.1093/rheumatology/kez061.012
Published: 29 March 2019
Journal Article
207. ANTI-PROTEINASE 3 IMMUNOGLOBULIN VARIABLE REGION LIGHT CHAIN GENES AND INCREASED FREQUENCY OF FAB GLYCOSYLATION SITES IN INFLAMED TISSUE OF ANCA-ASSOCIATED VASCULITIS
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez061.022, https://doi.org/10.1093/rheumatology/kez061.022
Published: 29 March 2019
Journal Article
195. DYING NEUTROPHILS CLEAVE INTERLEUKIN 33 INTO PRO-INFLAMMATORY ISOFORMS IN GRANULOMATOSIS WITH POLYANGIITIS
Rheumatology, Volume 58, Issue Supplement_2, March 2019, kez061.010, https://doi.org/10.1093/rheumatology/kez061.010
Published: 29 March 2019
Journal Article
CD4+CXCR4+ T cells as a novel prognostic biomarker in patients with idiopathic inflammatory myopathy-associated interstitial lung disease
Rheumatology, Volume 58, Issue 3, March 2019, Page 557, https://doi.org/10.1093/rheumatology/key425
Published: 22 December 2018
Journal Article
CD4+CXCR4+ T cells as a novel prognostic biomarker in patients with idiopathic inflammatory myopathy-associated interstitial lung disease Get access
Rheumatology, Volume 58, Issue 3, March 2019, Pages 511–521, https://doi.org/10.1093/rheumatology/key341
Published: 01 December 2018
Journal Article
Disability, fatigue, pain and their associates in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study
Rheumatology, Volume 57, Issue 2, February 2018, Pages 370–381, https://doi.org/10.1093/rheumatology/kex410
Published: 30 November 2017
Journal Article
Patient acceptable symptom state in scleroderma: results from the tocilizumab compared with placebo trial in active diffuse cutaneous systemic sclerosis
Rheumatology, Volume 57, Issue 1, January 2018, Pages 152–157, https://doi.org/10.1093/rheumatology/kex396
Published: 25 October 2017
Journal Article
Are interferon-related biomarkers advantageous for monitoring disease activity in systemic lupus erythematosus? A longitudinal benchmark study Get access
Rheumatology, Volume 56, Issue 9, September 2017, Pages 1618–1626, https://doi.org/10.1093/rheumatology/kex220
Published: 27 June 2017
